Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Prevent influenza virus infections systematically

29.01.2013
ViroSign - an interdisciplinary BMBF funded network

Influenza viruses close to a host cell

Viral epidemics and pandemics remain a constant threat for human population. This impact was particularly demonstrated by the recent transmission and explosive worldwide spread of a swine origin influenza virus among humans and the ongoing highly lethal infections with avian subtype strains.

Influenza virus infections are a major cause for respiratory disease, which affect all age groups and can occur repeatedly in any particular individual.

The newly established research network “ViroSign – Systems Virology of Influenza – Molecular Signature of permissive Virus Infection” is an interdisciplinary project that combines different aspects of systems biology ranging from the global system-wide analysis of cellular proteins to high-resolution microscopy of single viruses and mathematical modeling.

The aim is to unravel the interaction network of each viral component as well as the signature of all cellular proteins (proteome) produced by the host-cell as a response to the pathogen. Experiments and theory will be directed towards the identification of cellular interactors and viral proteins responsible for a specific host cell response. Bioinformatics will build upon these results and integrate previous data on studies as the identification of host cell factors required for virus replication. “This identification will allow the construction of a systemic model of influenza virus host interaction and will be useful for making predictions for the specific design and application of drugs and inhibitors to prevent infection”, explains Andreas Herrmann, Professor at the Department of Molecular Biophysics at Humboldt-Universität zu Berlin and ViroSign Co-ordinator.

The project is funded with 1,94 Mill. € by the Federal Ministry of Education and Research in the frame of the program e:Bio. Teams with complementary expertise of different institution in the Berlin region are involved: Integrative Research Institute (IRI) for the Life Sciences at Humboldt-Universität zu Berlin (Prof. Dr. Dr. h.c. Edda Klipp, Prof. Dr. Andreas Herrmann (co-ordinator)), Max-Planck-Institute for Infection Biology (Prof. Dr. Thomas Meyer), Robert-Koch-Institute Berlin (PD Dr. Thorsten Wolff) and Max-Delbrück-Center for Molecular Medicine (Prof. Dr. Matthias Selbach).

Contact
Prof. Dr. Andreas Herrmann
Humboldt-Universität zu Berlin
Department of Biology
Phone: +49 30 2093-8830
Andreas.Herrmann@rz.hu-berlin.de

Constanze Haase | idw
Further information:
http://www.hu-berlin.de

More articles from Life Sciences:

nachricht The malaria pathogen’s cellular skeleton under a super-microscope
18.04.2014 | Helmholtz-Zentrum für Infektionsforschung

nachricht Synapses – stability in transformation
17.04.2014 | Max Planck Institute of Neurobiology, Martinsried

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Anzeige

Anzeige

Event News

Siemens at the 2014 UIC ERTMS World Conference in Istanbul

01.04.2014 | Event News

AERA Meeting: German and US-American educational researchers in dialogue

28.03.2014 | Event News

WHS Regional Meeting: International experts address health challenges in Latin America

24.03.2014 | Event News

 
Latest News

A cross-section of the Universe

18.04.2014 | Physics and Astronomy

More, bigger wildfires burning western U.S., study shows

18.04.2014 | Studies and Analyses

High disease load reduces mortality of children

18.04.2014 | Social Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>